<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33737526</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>18</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions: Catalonia and Valencia.</ArticleTitle><Pagination><StartPage>6207</StartPage><MedlinePgn>6207</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6207</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-85395-z</ELocationID><Abstract><AbstractText>According to the degree of upper and lower motor neuron degeneration, motor neuron diseases (MND) can be categorized into amyotrophic lateral sclerosis (ALS), primary lateral sclerosis (PLS) or progressive muscular atrophy (PMA). Although several studies have addressed the prevalence and incidence of ALS, there is a high heterogeneity in their results. Besides this, neither concept has been previously studied in PLS or PMA. Thus, the objective of this study was to estimate the prevalence and incidence of MND, (distinguishing ALS, PLS and PMA), in the Spanish regions of Catalonia and Valencia in the period 2011-2019. Two population-based Spanish cohorts were used, one from Catalonia and the other from Valencia. Given that the samples that comprised both cohorts were not random, i.e., leading to a selection bias, we used a two-part model in which both the individual and contextual observed and unobserved confounding variables are controlled for, along with the spatial and temporal dependence. The prevalence of MND was estimated to be between 3.990 and 6.334 per 100,000 inhabitants (ALS between 3.248 and 5.120; PMA between 0.065 and 0.634; and PLS between 0.046 and 1.896), and the incidence between 1.682 and 2.165 per 100,000 person-years for MND (ALS between 1.351 and 1.754; PMA between 0.225 and 0.628; and PLS between 0.409-0.544). Results were similar in the two regions and did not differ from those previously reported for ALS, suggesting that the proposed method is robust and that neither region presents differential risk or protective factors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barcel&#xf3;</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Research Group On Statistics, Econometrics and Health (GRECS), University of Girona, Carrer de la Universitat de Girona 10, Campus de Montilivi, 17003, Girona, Spain. antonia.barcelo@udg.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain. antonia.barcelo@udg.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad Funcional de Motoneurona (UFMN), Instituto de Investigaci&#xf3;n Biom&#xe9;dica de Bellvitge (IDIBELL), Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. antonia.barcelo@udg.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Povedano</LastName><ForeName>M&#xf2;nica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unidad Funcional de Motoneurona (UFMN), Instituto de Investigaci&#xf3;n Biom&#xe9;dica de Bellvitge (IDIBELL), Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;zquez-Costa</LastName><ForeName>Juan F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Unidad Funcional de Motoneurona (UFMN), Instituto de Investigaci&#xf3;n Sanitaria La Fe (IIS La Fe), Hospital Universitario y Polit&#xe9;cnico La Fe, Valencia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine Department, Facultad de Medicina, University of Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franquet</LastName><ForeName>&#xc1;lvaro</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Research Group On Statistics, Econometrics and Health (GRECS), University of Girona, Carrer de la Universitat de Girona 10, Campus de Montilivi, 17003, Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3; Salut Empord&#xe0;, Figueres, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solans</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Group On Statistics, Econometrics and Health (GRECS), University of Girona, Carrer de la Universitat de Girona 10, Campus de Montilivi, 17003, Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saez</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Group On Statistics, Econometrics and Health (GRECS), University of Girona, Carrer de la Universitat de Girona 10, Campus de Montilivi, 17003, Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="N">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="N">Muscular Atrophy, Spinal</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33737526</ArticleId><ArticleId IdType="pmc">PMC7973725</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-85395-z</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-85395-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Chalabi A, Hardiman O, Kiernan MC, Chi&#xf2; A, Rix-Brooks B, van den Berg LH. Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol. 2016;2:1182&#x2013;1194. doi: 10.1016/S1474-4422(16)30199-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30199-5</ArticleId><ArticleId IdType="pubmed">27647646</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner, M.R., Talbot, K. Primary lateral sclerosis: diagnosis and management. Pract Neurol [Internet]. BMJ Publishing Group Ltd; 2020; Available from: https://pn.bmj.com/content/early/2020/03/25/practneurol-2019-002300</Citation></Reference><Reference><Citation>Turner, M.R., Barohn, R.J., Corcia, P., Fink, J.K., Harms, M.B., Kiernan, M.C., et al. Primary lateral sclerosis: consensus diagnostic criteria. Ajroud-Driss, S., Andrews, J.A., Babu, S., Bede, P., Benatar, M., Chew, S., et al., editors. J Neurol Neurosurg Psychiatry [Internet]. BMJ Publishing Group Ltd; 2020;91:373&#x2013;7. Available from: https://jnnp.bmj.com/content/91/4/373</Citation></Reference><Reference><Citation>Gordon, P.H., Cheng, B., Katz, I.B., Pinto, M., Hays, A.P., Mitsumoto, H., et al. The natural history of primary lateral sclerosis. Neurology [Internet]. 2006;66:647 LP &#x2013; 653. Available from: http://n.neurology.org/content/66/5/647.abstract</Citation><ArticleIdList><ArticleId IdType="pubmed">16534101</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser J, de Jong JMBV, de Visser M. The history of progressive muscular atrophy: Syndrome or disease? Neurol. U.S. 2008;70:723&#x2013;727.</Citation><ArticleIdList><ArticleId IdType="pubmed">18299524</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis. Curr. Opin. Neurol. Ovid Technol. (Wolters Kluwer Health) 2019;32:771&#x2013;776. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Belbasis L, Bellou V, Evangelou E. Environmental risk factors and amyotrophic lateral sclerosis: An umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies. Neuroepidemiol. Switzerland. 2016;46:96&#x2013;105. doi: 10.1159/000443146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443146</ArticleId><ArticleId IdType="pubmed">26731747</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesauro M, Consonni M, Filippini T, Mazzini L, Pisano F, Chio A, et al. Incidence of amyotrophic lateral sclerosis in the province of Novara, Italy, and possible role of environmental pollution. Amyotroph. Lateral Scler. Frontotemporal Degener. Engl. 2017;18:284&#x2013;290. doi: 10.1080/21678421.2017.1281961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1281961</ArticleId><ArticleId IdType="pubmed">28152620</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Traynor B, Collins J, Simeone J, Goldstein L, White L. Global epidemiology of amyotrophic lateral sclerosis: A systematic review of the published literature. Neuroepidemiology. 2013;41:118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsini M, Oliveira AB, Nascimento OJM, Reis CHM, Leite MAA, de Souza JA, et al. Amyotrophic lateral sclerosis: New perpectives and update. Neurol. Int. 2015;7:39&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4591493</ArticleId><ArticleId IdType="pubmed">26487927</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Liu T, Liu L, Yao X, Chen L, Fan D, et al. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Germany. 2020;267:944&#x2013;953. doi: 10.1007/s00415-019-09652-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09652-y</ArticleId><ArticleId IdType="pubmed">31797084</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson LM, Topol B, Kaye W, Williamson D, Horton DK, Mehta P, et al. Estimation of the prevalence of amyotrophic lateral sclerosis in the united states using national administrative healthcare data from 2002 to 2004 and capture-recapture methodology. Neuroepidemiol. Switzerland. 2018;51:149&#x2013;157. doi: 10.1159/000488798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000488798</ArticleId><ArticleId IdType="pmc">PMC6250049</ArticleId><ArticleId IdType="pubmed">30092573</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Kaye W, Raymond J, Punjani R, Larson T, Cohen J, et al. Prevalence of amyotrophic lateral sclerosis&#x2014;United States, 2015. MMWR Morb. Mortal Wkly. Rep. 2018;67:1285&#x2013;1289. doi: 10.15585/mmwr.mm6746a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6746a1</ArticleId><ArticleId IdType="pmc">PMC6289079</ArticleId><ArticleId IdType="pubmed">30462626</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton DK, Mehta P, Antao VC. Quantifying a nonnotifiable disease in the United States. JAMA. 2014;312:1097. doi: 10.1001/jama.2014.9799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.9799</ArticleId><ArticleId IdType="pmc">PMC4550214</ArticleId><ArticleId IdType="pubmed">25057819</ArticleId></ArticleIdList></Reference><Reference><Citation>Feigin VL, Vos T, Alahdab F, Amit AML, et al. Burden of neurological disorders across the US from 1990&#x2013;2017: A GlobalBurden of disease study. JAMA Neurol. 2020;2:e204152. doi: 10.1001/jamaneurol.2020.4152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.4152</ArticleId><ArticleId IdType="pmc">PMC7607495</ArticleId><ArticleId IdType="pubmed">33136137</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapata-Zapata CH, Franco Dager E, Aguirre-Acevedo DC, de Carvalho M, Solano-Atehortua J. Prevalence, incidence, and clinical-epidemiological characterization of amyotrophic lateral sclerosis in antioquia: Colombia. Neuroepidemiology. 2019;2:1&#x2013;7.</Citation></Reference><Reference><Citation>Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B. Epidemiology of amyotrophic lateral sclerosis: A review of literature. Rev Neurol (Paris) [Internet]. Elsevier Masson SAS; 2016;172:37&#x2013;45. 10.1016/j.neurol.2015.11.002</Citation></Reference><Reference><Citation>Marin B, Boumediene F, Logroscino G, Couratier P, Babron M-C, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: A meta-analysis. Int. J. Epidemiol. Engl. 2017;46:57&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, et al. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi Y, Atsuta N, Sobue G, Morita M, Nakano I. Prevalence and incidence of amyotrophic lateral sclerosis in Japan. J. Epidemiol. Japan. 2014;24:494&#x2013;499. doi: 10.2188/jea.JE20140059.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20140059</ArticleId><ArticleId IdType="pmc">PMC4213224</ArticleId><ArticleId IdType="pubmed">25373461</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995&#x2013;1997: A population-based study. Neurology. 1999;52(3):504&#x2013;509. doi: 10.1212/wnl.52.3.504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.52.3.504</ArticleId><ArticleId IdType="pubmed">10025778</ArticleId></ArticleIdList></Reference><Reference><Citation>Piemonte and Valle d'Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology. 2001;56(2):239&#x2013;44. doi: 10.1212/wnl.56.2.239.</Citation><ArticleIdList><ArticleId IdType="pubmed">11160962</ArticleId></ArticleIdList></Reference><Reference><Citation>Cima V, Logroscino G, D&#x2019;Ascenzo C, Palmieri A, Volpe M, Briani C, et al. Epidemiology of ALS in Padova district, Italy, from 1992 to 2005. Eur. J. Neurol. England. 2009;16:920&#x2013;924. doi: 10.1111/j.1468-1331.2009.02623.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02623.x</ArticleId><ArticleId IdType="pubmed">19473365</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaparte JP, Grant IA, Benstead TJ, Murray TJ, Smith M. ALS incidence in Nova Scotia over a 20-year-period: A prospective study. Can. J. Neurol. Sci. Engl. 2007;34:69&#x2013;73. doi: 10.1017/S0317167100005813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100005813</ArticleId><ArticleId IdType="pubmed">17352350</ArticleId></ArticleIdList></Reference><Reference><Citation>Instituto Nacional de Estad&#xed;stica (INE) [Available at: https://www.ine.es, last accessed on April 16, 2020].</Citation></Reference><Reference><Citation>Shefner JM, Al-Chalabi A, Baker MR, Cui L-Y, de Carvalho M, Eisen A, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol [Internet]. 2020; Available from: http://www.sciencedirect.com/science/article/pii/S1388245720301383</Citation><ArticleIdList><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Duque I, Dominguez-Berjon MF, Cebrecos A, Prieto-Salceda MD, Esnaola S, Calvo Sanchez M, et al. Deprivation index by enumeration district in Spain. Gac Sanit; 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32014314</ArticleId></ArticleIdList></Reference><Reference><Citation>INE. Instituto Nacional de Estad&#xed;stica. Indicators for census tracks. Population and Housing Census 2011 [in Spanish] [Available at: http://www.ine.es/censos2011_datos/cen11_datos_resultados_seccen.htm, last accessed on January 8, 2021].</Citation></Reference><Reference><Citation>INE. Cartograf&#xed;a digitalizada [Available at: www.ine.es/censos2011_datos/cen11_datos_resultados_seccen.htm, last accessed on January 8, 2021].</Citation></Reference><Reference><Citation>Cricelli C, Mazzaglia G, Samani F, Marchi M, Sabatini A, Nardi R, et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J. Public Health Med. Engl. 2003;25:254&#x2013;257. doi: 10.1093/pubmed/fdg060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdg060</ArticleId><ArticleId IdType="pubmed">14575204</ArticleId></ArticleIdList></Reference><Reference><Citation>Heckman JJ. Sample selection bias as a specification error author ( s ): James. J. Heckman. Econometrica. 1979;47:153&#x2013;161. doi: 10.2307/1912352.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/1912352</ArticleId></ArticleIdList></Reference><Reference><Citation>Heckman JJ. The Common Structure of Statistical Models of Truncation, Sample Selection and Limited Dependent Variables and a Simple Estimator for Such Models. Ann Econ Soc Meas [Internet]. 1976;5:475&#x2013;92. Available from: http://ideas.repec.org/h/nbr/nberch/10491.html</Citation></Reference><Reference><Citation>Saez M, Barcelo MA, Coll de Tuero G. A selection-bias free method to estimate the prevalence of hypertension from an administrative primary health care database in the Girona Health Region, Spain. Comput Methods Programs Biomed. Ireland; 2009;93:228&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">19059668</ArticleId></ArticleIdList></Reference><Reference><Citation>The R-INLA project. Random walk model of order 1. [Available at: http://www.math.ntnu.no/inla/r-inla.org/doc/latent/rw1.pdf, last accessed on January 8, 2021].</Citation></Reference><Reference><Citation>Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations (with discussion) J. R. Stat. Soc. Ser. B. 2009;71:319&#x2013;392. doi: 10.1111/j.1467-9868.2008.00700.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-9868.2008.00700.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson D, Rue H, Riebler A, Martins TG, Sorbye SH. Penalising Model Component Complexity: A Principled, Practical Approach to Constructing Priors. Stat Sci [Internet]. The Institute of Mathematical Statistics; 2017;32:1&#x2013;28. Available from: https://projecteuclid.org:443/euclid.ss/1491465621</Citation></Reference><Reference><Citation>Cheng J, Karambelkar B, Xie Y. leaflet: Create Interactive Web Maps with the JavaScript &#x2018;Leaflet&#x2019; Library. R package version 2.0.2. https://CRAN.R-project.org/package=leaflet, 2018.</Citation></Reference><Reference><Citation>R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2020 [Available at: https://www.R-project.org/, last accessed on January 8, 2021].</Citation></Reference><Reference><Citation>R INLA project, 2020 [Available at: http://www.r-inla.org/home, last accessed on January 8, 2021].</Citation></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C, Mazzini L, Mora G, Mutani R, et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: A population based study. J. Neurol. Neurosurg. Psychiatry. 2011;82:740&#x2013;746. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Redondo A, Dols-Icardo O, Rojas-Garcia R, Esteban-Perez J, Cordero-Vazquez P, Munoz-Blanco JL, et al. Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide. Hum. Mutat. U.S. 2013;34:79&#x2013;82. doi: 10.1002/humu.22211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22211</ArticleId><ArticleId IdType="pubmed">22936364</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamez J, Corbera-Bellalta M, Nogales G, Raguer N, Garcia-Arumi E, Badia-Canto M, et al. Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: Should all sporadic ALS cases also be screened for SOD1? J. Neurol. Sci. Netherlands. 2006;247:21&#x2013;28. doi: 10.1016/j.jns.2006.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.03.006</ArticleId><ArticleId IdType="pubmed">16674979</ArticleId></ArticleIdList></Reference><Reference><Citation>Liewluck T, Saperstein DS. Progressive muscular atrophy. Neurol Clin. United States. 2015;33:761&#x2013;773. doi: 10.1016/j.ncl.2015.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.005</ArticleId><ArticleId IdType="pubmed">26515620</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WK, Liu X, Sandner J, Pasmantier M, Andrews J, Rowland LP, et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology. 2010;74(23):1926. doi: 10.1212/WNL.0b013e3181e03ac0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181e03ac0</ArticleId><ArticleId IdType="pubmed">20530332</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, Vlam L, van Es MA, van der Pol WL, Hennekam EAM, Dooijes D, et al. Genetic overlap between apparently sporadic motor neuron diseases. PLoS ONE. 2012;7(11):e48983. doi: 10.1371/journal.pone.0048983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0048983</ArticleId><ArticleId IdType="pmc">PMC3498376</ArticleId><ArticleId IdType="pubmed">23155438</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradas J, Puig T, Rojas-Garc&#xed;a R, Viguera ML, Gich I, Logroscino G. Amyotrophic lateral sclerosis in Catalonia: A population based study. Amyotroph. Lateral Scler. Front. Degener. 2013;14:278&#x2013;283. doi: 10.3109/21678421.2012.749915.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.749915</ArticleId><ArticleId IdType="pubmed">23286747</ArticleId></ArticleIdList></Reference><Reference><Citation>Santurtun A, Villar A, Delgado-Alvarado M, Riancho J. Trends in motor neuron disease: Association with latitude and air lead levels in Spain. Neurol. Sci. 2016;37:1271&#x2013;1275. doi: 10.1007/s10072-016-2581-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-016-2581-2</ArticleId><ArticleId IdType="pubmed">27098242</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>